Results and Conclusions

Treg gates
Frequency of Treg subsets. Limitations:
•Small sample size •Resting primed Treg population include FOXP3 lo Ki-67 -nonregulatory and pro-inflammatory cytokine producing T cells.
Recommendations for Future Studies:
•Consider confounding factors common in TB endemic areas (nutritional status, co-infection with helminth, and exposure to Non-Tuberculous Mycobacteria).
CD4 + CD25 hi cells have the highest intensity of FOXP3; and their frequency is higher in TB patients than LTBI persons.
No difference in the frequency of Treg (defined by CD4 + CD25 + FOXP3 + CD127 lo ) among TB, LTBI, and EC.
Frequency of Treg subsets.
No difference in the frequency of Active Primed and Nave Treg subsets among TB, LTBI, and EC.
 Resting Primed Treg subset higher in EC than TB patients.
Fig. 4
The frequency of Treg subsets among study groups, Line at Median.
Change in Treg subsets in TB patients after treatment
 Activated primed subset of Treg (CD45RO + Ki-67 + ) are higher in TB disease and decline in frequency after treatment.
Nave subset of Treg are lower in active TB disease and increase after treatment.  No change in the intensity of FOXP3 in Treg subsets after treatment. 
FOXP3 expression in Treg subsets.
FOXP3 MFI is higher in activated primed Treg of TB patients than LTBI and EC. 
Gating strategy
